Drugs / CAR19 T cells carrying cytoplasmic activated PD-1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03540303 | Apr 2018 → Apr 2020 | non-Hodgkin lymphoma | Henan Cancer Hospital | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CAR19 T cells carrying cytoplasmic activated PD-1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03540303 ↗ |